Psoriasis Treatment Market Research, Size, Trends, Growth Factors, Segment Revenue Analysis Till 2030
Psoriasis is a highly common chronic skin condition. Market Research Future's (MRFR) in-depth market report on the psoriasis treatment market was valued USD 23.4 billion in 2021 and is expected to reach USD 48.33 billion by 2030 at 7.8% CAGR during the forecast period 2022-2030.
Rising
awareness and screening for psoriasis is the leading factor driving growth in
the demand for psoriasis treatment. This chronic condition is exacerbated by
several factors which can vary from patient to patient, thus further increasing
the demand for appropriate and effective treatment options. Increasing exposure
to chemicals and polluted environments have resulted in an increase in the
diagnosis of psoriasis. Presently, all treatment options are temporary in nature
or need ongoing patient involvement with no concrete cure. Drugs for psoriasis
treatment carry a high cost which will hamper market growth. However,
increasing adoptions of alternative psoriasis treatments, and the race among
market players to develop an effective psoriasis treatment solution will lead
to market opportunities.
Market
Segmentation
The global psoriasis
treatment market research is
segmented in MRFR's competitive analysis on the basis of mechanism of action,
route of administration, drug types, and region. Based on mechanism of action,
the market is segmented into interleukin blockers, phosphodiesterase
inhibitors, TNF inhibitors, and others.
By route of
administration, the market is divided between oral, injectable, and topical.
Oral treatment options are highly popular and capture around 40% of the global
market.
On the basis of
drug types, the market is segmented into biologics and small molecules.
Globally, the
market is divided into the Americas, Europe, Asia-Pacific (APAC), and the
Middle East and Africa.
Regional
Analysis
Due to the
presence of North America, the Americas account for the largest share of the
global market. The presence of several market players and a high patient population
afflicted with psoriasis is expected to lead to increased revenue generated for
market growth. Moreover, the awareness about this condition is quite high in
the region and has led to an increased demand for effective treatment options.
Increasing R&D activities to develop a long-term solution for psoriasis is
expected to facilitate market expansion opportunities.
Meanwhile, the
Asia Pacific is the fastest growing region due to the swiftly developing
healthcare sector and the growing awareness regarding conditions like psoriasis
which has resulted in increased demand. The affinity for natural skin care
methods is expected to reveal effective alternate treatment strategies that may
assist future market growth.
Key Players
Market leaders
who participate in the competitive landscape of the global psoriasis treatment
market include Eli Lilly, Novartis International AG, Johnson & Johnson,
Pfizer Inc., Merck and Co Inc., Amgen and AbbVie.
Latest Industry
News
Eli Lilly &
Company in Korea has received government approval from the Ministry of Health
& Welfare for the reimbursement for its psoriasis treatment drug Taltz.
Access Report @
https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769
About Market
Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York, New
York 10013
United States
of America
+1 628 258 0071
Email: sales@marketresearchfuture.com

Comments
Post a Comment